MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-DL-01-0023967
Aresko Life Sciences Private Limited
Aresko Life Sciences Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.87 Cr
▲ 35% YoY
Net loss · FY 2025
₹21.94 Cr
Net margin -78.7%
EBITDA · FY 2025
-₹18.07 Cr
EBITDA margin -64.8%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹73.6 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Employees · EPFO
93
Provident fund records
Directors on board
4
As per MCA filings
About Aresko Life Sciences Private Limited
Data last updated:
Aresko Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 September 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2022PTC405132. Its GSTIN is 07AAXCA6984B1Z6 (Delhi). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹73.6 Lakh. It is led by directors including Ajay Kumar Appukutty Vikaramparambil and Prithipal Singh Kochhar.
Its last annual general meeting (AGM) was held on 16 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 10 Jorbagh Market, New Delhi, Delhi, India – 110003.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.87 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net loss of ₹21.94 Cr (net margin -78.7%) and EBITDA of -₹18.07 Cr (EBITDA margin -64.8%).
The company has about 93 employees on its provident fund (EPFO) records.
Aresko Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-01-0023967). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24290DL2022PTC405132
Registration Number 405132
Incorporation Date 27 September 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 16 December 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-DL-01-0023967
Key People
Ajay Kumar Appukutty Vikaramparambil Director Prithipal Singh Kochhar Director Rajpal Singh Kochhar Director Recognitions & Rankings of Aresko Life Sciences
Contact details
Aresko Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address10 Jorbagh Market, New Delhi, Delhi, India – 110003
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aresko Life Sciences Private Limited, buy the company report.
Comprehensive company report
Aresko Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aresko Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aresko Life Sciences Private Limited, buy the company report.
Financials of Aresko Life Sciences Private Limited
FY 2025 filings availableAresko Life Sciences Private Limited reported revenue of ₹27.87 Cr (up 35% YoY) for FY 2025.
Revenue · FY 2025
₹27.87 Cr ▲ 35%
Net loss · FY 2025
₹21.94 Cr margin -78.7%
EBITDA · FY 2025
-₹18.07 Cr margin -64.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
EBITDA CAGR growth
1 year
▼ 168%
Revenue rose 35% in the latest year. EBITDA fell 168% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹18.07 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹21.94 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -64.8% | ||
| Net Profit Margin | -78.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Aresko Life Sciences Private Limited, buy the company report.
Board of directors of Aresko Life Sciences Private Limited
Aresko Life Sciences has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Kumar Appukutty Vikaramparambil | Director | Current | ||
| Prithipal Singh Kochhar Also directs: Aresko Global LLP, I.K. Enterprises Private Limited, Suvinys Developers Private Limited and 5 more | Director | 27 Sep 2022 | 4 Years 1 Months | Current |
| Rajpal Singh Kochhar | Director | 27 Sep 2022 | 4 Years 1 Months | Current |
| Venkata Laxmi Subramanyam Vemuri | Director | 10 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Aresko Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asg Biochem Private Limited | ₹28.92 Cr (FY 2025) | -9.0% | New Delhi, Delhi, India | |||
| Livmore Life Sciences Private Limited | ₹28.89 Cr (FY 2025) | 296.0% | Vadodara, Gujarat, India | |||
| Surya Remedies Private Limited | ₹28.86 Cr (FY 2024) | 9.0% | Ankleshwar, Gujarat, India | |||
| Pranami Drugs Private Limited | ₹28.27 Cr (FY 2025) | 17.0% | Ankleshwar, Gujarat, India | |||
| Parmax Pharma Limited | ₹28.24 Cr (FY 2025) | 154.0% | Hadamtala, Gujarat, India | |||
| Aresko Life Sciences Private Limitedthis company | ₹27.87 Cr (FY 2025) | -₹21.94 Cr | -78.7% | 35.0% | New Delhi, Delhi, India | |
| Progress Life Sciences Private Limited | ₹27.83 Cr (FY 2025) | 1.0% | Navi Mumbai, Maharashtra, India | |||
| Nandu Chemicals Private Limited | ₹27.74 Cr (FY 2025) | 16.0% | Hubli, Karnataka, India | |||
| Enzal Chemicals (India) Limited | ₹27.7 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India | |||
| Altra Pharma-Chem Private Limited | ₹27.64 Cr (FY 2024) | -36.0% | Thane, Maharashtra, India | |||
| Strides Chemicals Private Limited | ₹27.39 Cr (FY 2019) | -24.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Aresko Life Sciences Private Limited, buy the company report.
Auditor
Aresko Life Sciences Private Limited is audited by Walker Chandiok &Co LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Walker Chandiok &Co LLP | FY 2023 | AAAFW4298E |
Shareholding
The shareholding of Aresko Life Sciences Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Aresko Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aresko Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Aresko Life Sciences Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 28 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Quick Freight Systems Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Aresko Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Aresko Life Sciences has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAXCA6984B1Z6 | Delhi | Active | 11 Nov 2022 |
| 05AAXCA6984B1ZA | Uttarakhand | Active | 16 Oct 2023 |
| 09AAXCA6984B1Z2 | Uttar Pradesh | Active | 03 Nov 2023 |
To see the full GST registrations and return filing status of Aresko Life Sciences Private Limited, buy the company report.
Recent activity
Aresko Life Sciences Private Limited has 5 board changes on record since 2022: 3 appointments and 2 cessations. The latest: Venkata Laxmi Subramanyam Vemuri ceased to be Additional Director on 15 Dec 2025.
AGM
Aresko Life Sciences Private Limited last Annual general meeting of members was held on 16 Dec 2025 as per latest MCA records.
Ceased
Venkata Laxmi Subramanyam Vemuri ceased to be Additional Director.
Filing
Aresko Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Venkata Laxmi Subramanyam Vemuri was appointed as Director.
Ceased
Ajay Kumar Appukutty Vikaramparambil ceased to be Additional Director.
Appointed
Prithipal Singh Kochhar was appointed as Director.
Appointed
Rajpal Singh Kochhar was appointed as Director.
Incorporation
27 Sep 2022
Aresko Life Sciences Private Limited was registered on 27 Sep 2022 with Roc Delhi & aged 4 years 1 month as per MCA records.
Frequently asked questions
Aresko Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 September 2022 (4+ years old) and is registered under CIN U24290DL2022PTC405132.
Aresko Life Sciences has 4 current directors:
- Ajay Kumar Appukutty Vikaramparambil - Director
- Prithipal Singh Kochhar - Director
- Rajpal Singh Kochhar - Director
- Venkata Laxmi Subramanyam Vemuri - Director
The latest financial statements of Aresko Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 16 December 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Aresko Life Sciences is 07AAXCA6984B1Z6, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 05AAXCA6984B1ZA (Uttarakhand), 09AAXCA6984B1Z2 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Aresko Life Sciences is U24290DL2022PTC405132. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aresko Life Sciences was incorporated on 27 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aresko Life Sciences by revenue are Asg Biochem Private Limited, Livmore Life Sciences Private Limited, Surya Remedies Private Limited, Pranami Drugs Private Limited, Parmax Pharma Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Venkata Laxmi Subramanyam Vemuri ceased to be Additional Director on 15 Dec 2025. Venkata Laxmi Subramanyam Vemuri was appointed as Director on 10 Feb 2025. Ajay Kumar Appukutty Vikaramparambil ceased to be Additional Director on 29 Dec 2023. Aresko Life Sciences has 5 board changes on record in total.
Yes, Aresko Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-DL-01-0023967).
Aresko Life Sciences has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 28 overdue payments to 11 micro and small suppliers. The latest return was filed on 01 May 2024.
The registered office of Aresko Life Sciences is at 10 Jorbagh Market, New Delhi, Delhi, India – 110003.
Aresko Life Sciences operates in the pharma industry, in the drug formulation and development segment.